PEPG
NASDAQ
$2.20
PepGen Inc (PEPG)
PepGen Inc., a clinical-stage biotechnology company, is focused on the development of oligonucleotide therapeutics for use in the treatment of serious neurological and neuromuscular diseases. The company is headquartered in Cambridge, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $10.25 (+365.91%)
Market Cap
$169M
Free Cash Flow Yield
-45.76%
Beta (5Y)
0.79
Price Chart
Valuation
Market Cap$169M
P/B1.24
Profitability
EBITDA-$80M
EPS-$2.37
Financial Health
Free Cash Flow Yield-45.76%
Growth & Risk
Beta (5Y)0.79
Sharpe Ratio0.98